Trophoblast CD200 expression in successful human pregancies and missed abortions

被引:6
|
作者
Clark, David A. [1 ,2 ]
McCready, M. Elizabeth [2 ,3 ]
Harris, Kate [3 ]
Malloy, Leslie [3 ]
Arredondo, Jorge L. [2 ]
机构
[1] McMaster Univ, Dept Med, HSC Rm 3H1E, Hamilton, ON L8S 4K1, Canada
[2] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada
[3] McMaster Univ, Hamilton Hlth Sci, Hamilton Reg Lab Med Program, Cytogenet Lab,Med Ctr, 1200 Main St E, Hamilton, ON L8N 3Z5, Canada
关键词
CD200; Missed abortion; receptors; Placenta; Trophoblasts; RECEPTOR FAMILY;
D O I
10.1016/j.jri.2018.03.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Presence of the CD200 immune check-point inhibitor at the feto-maternal interface is linked to prevention of spontaneous abortion in mice and humans. In human missed abortions (MA), absence of Th17-driven inflammation has been attributed to expression of villus trophoblast CD200 quantified using immunohistochemistry. While rapid aneuploidy (QF-PCR) testing linked low CD200 to pregnancy failure, data showing normal VT CD200 in first trimester normal pregnancy and in abortion of chromosomally abnormal embryos has not been demonstrated. The present report shows normal CD200 in a 7 week gestation termination with normal male QF-PCR and in a 10 week male trisomy 18 MA.
引用
收藏
页码:55 / 57
页数:3
相关论文
共 50 条
  • [31] CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas
    Rita T. Lawlor
    Valentina Daprà
    Ilaria Girolami
    Antonio Pea
    Camilla Pilati
    Alessia Nottegar
    Paola Piccoli
    Claudia Parolini
    Nicola Sperandio
    Paola Capelli
    Aldo Scarpa
    Claudio Luchini
    Virchows Archiv, 2019, 474 : 105 - 109
  • [32] CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas
    Lawlor, Rita T.
    Dapra, Valentina
    Girolami, Ilaria
    Pea, Antonio
    Pilati, Camilla
    Nottegar, Alessia
    Piccoli, Paola
    Parolini, Claudia
    Sperandio, Nicola
    Capelli, Paola
    Scarpa, Aldo
    Luchini, Claudio
    VIRCHOWS ARCHIV, 2019, 474 (01) : 105 - 109
  • [33] Analysis of CD200 expression in B cells lymphoproliferative disorders
    Raspadori, D.
    Tassi, M.
    Dell'Aversano, M. A.
    Parigi, S.
    Chitarrelli, I
    Toraldo, F.
    Lenoci, M.
    Lauria, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 112 - 113
  • [34] Expression and Diagnostic Utility of CD200 in Hematologic Malignancies.
    Coviello-Malle, J.
    Alapat, D.
    Barlogie, B.
    Shaughnessy, J. D.
    Lorsbach, R. B.
    LABORATORY INVESTIGATION, 2011, 91 : 292A - 292A
  • [35] CD200 expression level is associated with outcome in multiple myeloma
    Chen, Lijuan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E174 - E175
  • [36] CD200 Expression in Non-Myeloma Immunoproliferative Disorders
    Olteanu, H.
    Harrington, A. M.
    Kroft, S. H.
    MODERN PATHOLOGY, 2012, 25 : 358A - 359A
  • [37] Immunophenotypic Stability of CD200 Expression in Plasma Cell Myeloma
    Olteanu, Horatiu
    Harrington, Alexandra M.
    Kroft, Steven H.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (06) : 1013 - 1014
  • [38] Clinical Importance of CD200 Expression in Colorectal Liver Metastasis
    Yasuko Matsuo
    Masayuki Sho
    Takeo Nomi
    Daisuke Hokuto
    Takahiro Yoshikawa
    Naoki Kamitani
    Kota Nakamura
    Yosuke Iwasa
    Annals of Surgical Oncology, 2021, 28 : 5362 - 5372
  • [39] Expression and Diagnostic Utility of CD200 in Hematologic Malignancies.
    Coviello-Malle, J.
    Alapat, D.
    Barlogie, B.
    Shaughnessy, J. D.
    Lorsbach, R. B.
    MODERN PATHOLOGY, 2011, 24 : 292A - 292A
  • [40] CD200 Expression in Non-Myeloma Immunoproliterative Disorders
    Olteanu, H.
    Harrington, A. M.
    Kroft, S. H.
    LABORATORY INVESTIGATION, 2012, 92 : 358A - 359A